Cargando…
Therapeutic Efficacy of Potent Neutralizing HIV-1-Specific Monoclonal Antibodies in SHIV-Infected Rhesus Monkeys
HIV-1-specific monoclonal antibodies (mAbs) with extraordinary potency and breadth have recently been described. In humanized mice, combinations of mAbs have been shown to suppress viremia, but the therapeutic potential of these mAbs has not yet been evaluated in primates with an intact immune syste...
Autores principales: | Barouch, Dan H., Whitney, James B., Moldt, Brian, Klein, Florian, Oliveira, Thiago Y., Liu, Jinyan, Stephenson, Kathryn E., Chang, Hui-Wen, Shekhar, Karthik, Gupta, Sanjana, Nkolola, Joseph P., Seaman, Michael S., Smith, Kaitlin M., Borducchi, Erica N., Cabral, Crystal, Smith, Jeffrey Y., Blackmore, Stephen, Sanisetty, Srisowmya, Perry, James R., Beck, Matthew, Lewis, Mark G., Rinaldi, William, Chakraborty, Arup K., Poignard, Pascal, Nussenzweig, Michel C., Burton, Dennis R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4017780/ https://www.ncbi.nlm.nih.gov/pubmed/24172905 http://dx.doi.org/10.1038/nature12744 |
Ejemplares similares
-
Rapid Seeding of the Viral Reservoir Prior to SIV Viremia in Rhesus Monkeys
por: Whitney, James B., et al.
Publicado: (2014) -
HIV envelope antibodies and TLR7 agonist partially prevent viral rebound in chronically SHIV-infected monkeys
por: Moldt, Brian, et al.
Publicado: (2022) -
Adenovirus prime, Env protein boost vaccine protects against neutralization-resistant SIVsmE660 variants in rhesus monkeys
por: Keele, Brandon F., et al.
Publicado: (2017) -
Therapeutic efficacy of combined active and passive immunization in ART-suppressed, SHIV-infected rhesus macaques
por: Walker-Sperling, Victoria E. K., et al.
Publicado: (2022) -
Antibody and TLR7 Agonist Delay Viral Rebound in SHIV-Infected Monkeys
por: Borducchi, Erica N., et al.
Publicado: (2018)